Therapeutic targeting of STAT3 pathways in pancreatic adenocarcinoma: A systematic review of clinical and preclinical literature.
<h4>Background/objectives</h4>Pancreatic ductal adenocarcinoma is a highly lethal disease with increasing incidence. Due to high resistance, chemo/radiotherapy has limited success in pancreatic cancer and only marginally prolongs patient survival. Therefore, novel biomarkers and therapeu...
Enregistré dans:
Auteurs principaux: | Sarah Peisl, Claudia Mellenthin, Lucie Vignot, Carmen Gonelle-Gispert, Leo Bühler, Bernhard Egger |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/dc7287d69a68460e8e28be95741b3bed |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Therapeutic Targeting of Autophagy in Pancreatic Ductal Adenocarcinoma
par: Alexander G. Raufi, et autres
Publié: (2021) -
Immune checkpoint inhibition for pancreatic ductal adenocarcinoma: limitations and prospects: a systematic review
par: Hong-Bo Li, et autres
Publié: (2021) -
Advances in Pancreatic Ductal Adenocarcinoma Treatment
par: Eric M. Anderson, et autres
Publié: (2021) -
A preclinical model of chronic pancreatitis driven by trypsinogen autoactivation
par: Andrea Geisz, et autres
Publié: (2018) -
Therapeutic effects of micro-RNAs in preclinical studies of acute kidney injury: a systematic review and meta-analysis
par: Sarah Zankar, et autres
Publié: (2021)